Emergent BioSolutions Inc. (EBS)
USD 8.16
(-7.17%)
USD 8.16
(-7.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.04 Billion | 1.12 Billion | 1.79 Billion | 1.55 Billion | 1.1 Billion | 782.4 Million |
| Cost of Revenue | 705.4 Million | 693.7 Million | 757.5 Million | 524 Million | 433.5 Million | 322.3 Million |
| Gross Profit | 343.9 Million | 427.2 Million | 1.03 Billion | 1.03 Billion | 672.5 Million | 460.1 Million |
| Operating Expenses | 1.04 Billion | 593.2 Million | 640.9 Million | 597.6 Million | 558.4 Million | 370.3 Million |
| Selling, General and Administrative Expenses | 368.4 Million | 340.3 Million | 348.4 Million | 303.3 Million | 273.5 Million | 202.5 Million |
| Research and Development Expenses | 111.4 Million | 193 Million | 234 Million | 234.5 Million | 226.2 Million | 142.8 Million |
| Other Expenses | 564.2 Million | 59.9 Million | 58.5 Million | 59.8 Million | 58.7 Million | 1.6 Million |
| Cost and Expenses | 1.74 Billion | 1.28 Billion | 1.39 Billion | 1.12 Billion | 991.9 Million | 692.6 Million |
| Operating Income | -726.4 Million | -166 Million | 352.6 Million | 433.8 Million | 114.1 Million | 89.8 Million |
| Interest Expense | 87.9 Million | 37.3 Million | 34.5 Million | 31.3 Million | 38.4 Million | 9.9 Million |
| Income Tax Expense | 29.3 Million | 2.1 Million | 83.5 Million | 102.1 Million | 22.9 Million | 18.8 Million |
| Earnings before Tax | -731.2 Million | -221.7 Million | 314.4 Million | 407.2 Million | 77.4 Million | 81.5 Million |
| Net Income | -760.5 Million | -223.8 Million | 219.5 Million | 305.8 Million | 54.5 Million | 62.7 Million |
| Earnings Per Share Basic | -14.85 | -4.47 | 4.10 | 5.79 | 1.06 | 1.25 |
| Earnings Per Share Diluted | -14.85 | -4.47 | 4.06 | 5.67 | 1.04 | 1.22 |
| Weighted Average Shares Outstanding | 51.2 Million | 50.1 Million | 53.5 Million | 52.7 Million | 51.5 Million | 50.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.2 Million | 50.1 Million | 54.1 Million | 53.8 Million | 52.4 Million | 51.4 Million |
| Gross Margin | 0.33 | 0.38 | 0.58 | 0.66 | 0.61 | 0.59 |
| EBIT Margin | -0.48 | -0.03 | 0.29 | 0.36 | 0.20 | 0.15 |
| Profit Margin | -0.72 | -0.20 | 0.12 | 0.20 | 0.05 | 0.08 |
| EBITDA | -505.29 Million | -32.9 Million | 458.2 Million | 549 Million | 227.3 Million | 152.7 Million |
| Earnings Before Tax Margin | -0.69 | -0.15 | 0.20 | 0.28 | 0.10 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 254.7 Million | 300.4 Million | 1.04 Billion | 276.6 Million | 270.5 Million | 337.9 Million |
| Cost of Revenue | 309.2 Million | 161 Million | 756.8 Million | 201.8 Million | 176.8 Million | 190.6 Million |
| Gross Profit | -54.5 Million | 139.4 Million | 292.5 Million | 74.8 Million | 93.7 Million | 147.3 Million |
| Operating Expenses | 104.6 Million | 99.6 Million | 464.5 Million | 116.7 Million | 117.6 Million | 133.5 Million |
| Selling, General and Administrative Expenses | 77.3 Million | 84.6 Million | - | 87.5 Million | 86 Million | 91.4 Million |
| Research and Development Expenses | 27.3 Million | 15 Million | - | 29.2 Million | 15.3 Million | 26 Million |
| Other Expenses | -2.7 Million | -3.4 Million | 8.9 Million | 11 Million | -3.4 Million | -3.6 Million |
| Cost and Expenses | 413.8 Million | 260.6 Million | 1.22 Billion | 318.5 Million | 294.4 Million | 324.1 Million |
| Operating Income | -159.1 Million | 39.8 Million | -172 Million | -41.9 Million | -242.1 Million | -292.9 Million |
| Interest Expense | 23.6 Million | 24.3 Million | 96.8 Million | 22.2 Million | 19.7 Million | 28.6 Million |
| Income Tax Expense | 13.3 Million | 3.1 Million | 29.3 Million | -5 Million | 16.3 Million | 11.1 Million |
| Earnings before Tax | -269.8 Million | 12.1 Million | -731.2 Million | -54.5 Million | -265.9 Million | -250.2 Million |
| Net Income | -283.1 Million | 9 Million | -760.5 Million | -49.5 Million | -265.9 Million | -261.3 Million |
| Earnings Per Share Basic | -5.38 | 0.17 | - | -0.95 | -5.13 | -5.15 |
| Earnings Per Share Diluted | -5.38 | 0.17 | - | -0.95 | -5.13 | -5.15 |
| Weighted Average Shares Outstanding | 52.6 Million | 52.2 Million | 51.2 Million | 51.9 Million | 51.8 Million | 50.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.6 Million | 52.2 Million | 51.2 Million | 51.9 Million | 51.8 Million | 50.7 Million |
| Gross Margin | -0.21 | 0.46 | 0.28 | 0.27 | 0.35 | 0.44 |
| EBIT Margin | -0.51 | 0.23 | - | -0.04 | -0.04 | 0.13 |
| Profit Margin | -1.11 | 0.03 | -0.72 | -0.18 | -0.98 | -0.77 |
| EBITDA | -129.69 Million | 68.6 Million | - | -11.4 Million | -11 Million | 43.1 Million |
| Earnings Before Tax Margin | -0.62 | 0.13 | -0.16 | -0.15 | -0.90 | -0.87 |
NMTP
BGEO
FSTF
BRW
TELL
GAL